Altogether, we describe compelling clinical and experimental data to substantiate variants in TULP3 as a monogenic cause of progressive degenerative liver fibrosis with variable fibrocystic kidney disease and hypertrophic cardiomyopathy. This evidence concerns the gene TULP3 and hypertrophic cardiomyopathy.